Sector: MedicalClinical Data, Inc. (NASDAQ: CLDA)
Ranking History
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 221 |
Technical : | 4 |
Performance : | 8 |
Overall: | 25 |
Number of Stocks: | 306 |
Scan Date: | 10/20/2009 |
Sector: | Medical |
Funamental : | 224 |
Technical : | 19 |
Performance : | 3 |
Overall: | 21 |
Number of Stocks: | 305 |
Scan Date: | 10/15/2009 |
Sector: | Medical |
Funamental : | 226 |
Technical : | 47 |
Performance : | 2 |
Overall: | 39 |
Number of Stocks: | 305 |
Headlines
- Clinical Data, Inc. Prices Public Offering of Common Stock
Oct 28, 2009 09:26 AM | CLDA, PJC
- Clinical Data, Inc. Announces Public Offering of Common Stock
Oct 27, 2009 04:01 PM | CLDA, PJC
- Celldex Therapeutics (NASDAQ: CLDX): Plenty of Cash and Pending Clinical Catalysts
Oct 19, 2009 10:24 PM | BMY, CLDA, CRGN, GSK, MEDX
- FDA Calendar Extreme Trades: 85 Single Digit Stocks
Oct 13, 2009 12:34 PM | ACCP, APOL, CLDA, CRI, CRL, CYTX
- Clinical Data, Inc. to Host Investor Day and Webcast October 8, 2009
Oct 05, 2009 10:00 AM | CLDA
- Clinical Data, Inc. to Present at the JMP Securities Healthcare Focus Conference
Sep 29, 2009 01:25 PM | CLDA
- Clinical Data, Inc. Announces Pharmaceutical Industry Leader Joins the Board of Directors
Sep 18, 2009 07:30 AM | CLDA, PRX
- Clinical Data, Inc. to Present at the Rodman & Renshaw 11th Annual Healthcare Conference
Sep 03, 2009 07:45 AM | CLDA
- Intrexon Announces Purchase of Industry-Leading Bioassay Operation
Sep 01, 2009 07:10 AM | CLDA
- Clinical Data, Inc. Sells Certain Non-Core Assets to Intrexon Corporation
Sep 01, 2009 07:05 AM | CLDA
- Clinical Data, Inc. Reports First Quarter Fiscal 2009 Results
Aug 10, 2009 07:51 AM | CLDA
- Clinical Data, Inc. to Present at BMO Capital Markets’ Ninth Annual Focus on Healthcare Conference August 5th
Jul 29, 2009 04:24 PM | CLDA
- Clinical Data, Inc. Announces Approval of Generic Name Vilazodone, First in a New Class of Experimental Treatments for Depression
Jun 19, 2009 04:29 PM | CLDA
- Clinical Data, Inc. Reports Fourth Quarter and Fiscal Year 2009 Results
Jun 15, 2009 07:52 AM | CLDA
- Clinical Data, Inc. to Present at Noble Financial’s Fifth Annual Equity Conference
Jun 04, 2009 05:20 PM | CLDA
- Clinical Data, Inc. Announces Positive Results from Second Phase III Trial of Vilazodone for Depression
Jun 02, 2009 06:03 AM | CLDA
- Clinical Data Completes Acquisition of Avalon Pharmaceuticals
May 28, 2009 04:10 PM | CLDA
- Clinical Data, Inc. and Dana-Farber Cancer Institute Form Research Collaboration to Study Role of FCGR3A Gene Variants for Predicting Clinical Outcomes in Breast Cancer Treatment
May 18, 2009 08:31 AM | CLDA
- Clinical Data, Inc. to Present at the Eighth Annual JMP Securities Research Conference
May 14, 2009 08:18 AM | CLDA
- Clinical Data, Inc. Expands FAMILION® Long QT Syndrome Test by Doubling the Number of Genes
May 13, 2009 08:23 AM | CLDA
- Form 3/A Tarriff Scott For: Sep 17 (10K)
Sep 22, 2009 07:51 PM
- Form 4 CLINICAL DATA INC For: Sep 17 Filed by: KIRK RANDAL J (10K)
Sep 21, 2009 05:23 PM
- Form 4 HORNER LARRY D /FA For: Sep 17 (10K)
Sep 18, 2009 04:04 PM
- Form 4 CLINICAL DATA INC For: Sep 17 Filed by: MALMAN ARTHUR B (10K)
Sep 18, 2009 03:59 PM
- Form 4 Wallace Richard John For: Sep 17 (10K)
Sep 18, 2009 03:52 PM
- Form 4 Tarriff Scott For: Sep 17 (10K)
Sep 18, 2009 03:47 PM
- Form 3 Tarriff Scott For: Sep 17 (10K)
Sep 18, 2009 03:44 PM
- Form 4 SOBEL BURTON E For: Sep 17 (10K)
Sep 18, 2009 03:39 PM
- Form 4 Reed Carol For: Dec 22 (10K)
Dec 23, 2008 06:44 PM
- Form 4 Fromkin Drew J For: Dec 22 (10K)
Dec 23, 2008 06:44 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
CLDA
|
Compare to S&P
|
| YTD |
77.30 %
|
54.56 %
|
| 4 Weeks |
-4.36 %
|
-5.38 %
|
| 12 Weeks |
9.20 %
|
6.49 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 8.14 %
|
|
EPS Growth in Last Year: -11.27 %
|
|
Sales Growth in Last Quarter: 14.61 %
|
|
Sales Growth in Last Quarter: -59.79 %
|
|
